Discover 1,776 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,776
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
for
Smoldering Plasma Cell Myeloma
Location: Chapel Hill NC, Kenansville NC, Kinston NC, Greer SC,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT03937635
Phase 3, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Location: Chapel Hill NC, Charlotte NC, Fairfax VA, Bluffton SC,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 12+
Code: NCT02693535
Phase 2, Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
for
Refractory Differentiated Thyroid Gland Carcinoma
Location: Chapel Hill NC, Durham NC, Charleston SC, Lexington KY,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06475989
Phase 3, Recruiting
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
for
Smoldering Multiple Myeloma
Location: Durham NC, Charlotte NC, Richmond VA, Columbus OH,
Sponsor: Tufts Medical Center
Sex: All
Age: 40+
Code: NCT06365060
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Location: Chapel Hill NC, Baltimore MD, New York NY
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 18+
Code: NCT07331324
Recruiting
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
for
Hemolytic Disease of the Fetus and Newborn
Location: Chapel Hill NC, Norfolk VA, Lexington KY, Baltimore MD,
Sponsor: Janssen Research & Development, LLC
Sex: Female
Age: 18 - 45
Code: NCT05912517
Phase 3, Recruiting
CHAMPION: A Study to Evaluate the Efficacy and Safety of Obudanersen (ION582) in Children and Adults With Angelman Syndrome (AS)
for
Angelman Syndrome
Location: Carrboro NC
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All
Age: 2 - 50
Code: NCT07782827
Phase 3, Recruiting
BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.
for
Angelman Syndrome
Location: Chapel Hill NC, Nashville TN, Chicago IL, Miami FL,
Sponsor: OHB Pediatrics Ltd.
Sex: All
Age: 1 - 50
Code: NCT07605429
Phase 3, Recruiting
A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)
for
Type-2 Diabetes Mellitus
Location: Chapel Hill NC, Scottsdale AZ, Newport Beach CA
Sponsor: Aqua Medical, Inc.
Sex: All
Age: 22 - 65
Code: NCT07355270
Recruiting
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices